ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
Aperta Biosciences, LLCNot yet recruiting
-
Hospices Civils de LyonNot yet recruitingUrinary Incontinence | Neurogenic Bladder | Urinary Diversion | Pelvic Malignancy | Urinary Bladder CarcinomaFrance
-
Second Affiliated Hospital, Zhejiang University...RecruitingNormal Hearing | Noise Exposure | Preferred Loudness LevelChina
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingClear Cell Renal Cell Carcinoma | Ovarian Cancer | Other Advanced Solid TumorsChina
-
University Hospital, AntwerpNot yet recruitingNecrotizing Enterocolitis of Newborn | Late Onset Neonatal SepsisBelgium, Netherlands
-
VA Office of Research and DevelopmentNot yet recruitingMetastatic Non-Small Cell Lung Cancer | Cancer-Associated Weight Loss | Elevated Inflammatory MarkersUnited States
-
ENTire Medical Ltd.Not yet recruitingHypertrophy | Tonsillectomy | Airway Obstruction Upper | Adenoidectomy SurgeryUnited States
-
AbbVieNot yet recruitingModerate to Severe Psoriasis
-
Institute of Hematology & Blood Diseases Hospital...RecruitingAplastic Anemia | Clonal Hematopoiesis | Immunosuppressive TherapyChina
-
Ahmed Nasser Ali MabkhoutRecruitingJaw Cysts | Alveolar Bone DefectsYemen
-
University of CoimbraNot yet recruiting
-
AbbVieNot yet recruiting
Clinical Research Jobs
-
United States - Ohio - Cincinnati
-
United States - Shrewsbury
-
China
-
India - Kochi
-
Serbia - Belgrade
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China